文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

埃博拉出血热。

Ebola haemorrhagic fever.

机构信息

Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, MT, USA.

出版信息

Lancet. 2011 Mar 5;377(9768):849-62. doi: 10.1016/S0140-6736(10)60667-8.


DOI:10.1016/S0140-6736(10)60667-8
PMID:21084112
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3406178/
Abstract

Ebola viruses are the causative agents of a severe form of viral haemorrhagic fever in man, designated Ebola haemorrhagic fever, and are endemic in regions of central Africa. The exception is the species Reston Ebola virus, which has not been associated with human disease and is found in the Philippines. Ebola virus constitutes an important local public health threat in Africa, with a worldwide effect through imported infections and through the fear of misuse for biological terrorism. Ebola virus is thought to also have a detrimental effect on the great ape population in Africa. Case-fatality rates of the African species in man are as high as 90%, with no prophylaxis or treatment available. Ebola virus infections are characterised by immune suppression and a systemic inflammatory response that causes impairment of the vascular, coagulation, and immune systems, leading to multiorgan failure and shock, and thus, in some ways, resembling septic shock.

摘要

埃博拉病毒是一种在人类中引起严重病毒性出血热(称为埃博拉出血热)的病原体,在中非地区流行。唯一的例外是雷斯顿埃博拉病毒,它与人类疾病无关,在菲律宾发现。埃博拉病毒在非洲构成了重要的当地公共卫生威胁,通过输入性感染和对生物恐怖主义滥用的恐惧,对全球产生影响。埃博拉病毒也被认为对非洲的大型猿类种群有不利影响。在人类中,非洲物种的病死率高达 90%,目前尚无预防或治疗方法。埃博拉病毒感染的特征是免疫抑制和全身性炎症反应,导致血管、凝血和免疫系统受损,导致多器官衰竭和休克,因此在某些方面类似于感染性休克。

相似文献

[1]
Ebola haemorrhagic fever.

Lancet. 2011-3-5

[2]
Ebola Virus: Another Challenge from the Deadly Viral Brigade.

J Assoc Physicians India. 2014-9

[3]
Retracted: Ebola virus: an introduction and its pathology.

Rev Med Virol. 2016-1

[4]
[Ebola virus disease in West Africa and Germany : clinical presentation, management and practical experience with medevacuated patients in Germany].

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015-7

[5]
[Ebola virus disease].

Folia Med Cracov. 2014

[6]
Focus on Ebola virus research.

Viral Immunol. 2015-2

[7]
[Ebola: "a fatal syndrome"].

Bol Asoc Med P R. 1996

[8]
General introduction into the Ebola virus biology and disease.

Folia Med Cracov. 2014

[9]
Ebola hemorrhagic fever outbreaks: strategies for effective epidemic management, containment and control.

Braz J Infect Dis. 2015

[10]
[Marburg and Ebola hemorrhagic fevers--pathogens, epidemiology and therapy].

Med Monatsschr Pharm. 2014-9

引用本文的文献

[1]
Small molecule drug discovery for Ebola virus disease.

RSC Med Chem. 2025-8-6

[2]
Ebola Virus Disease: Uniquely Challenging Among the Viral Hemorrhagic Fevers.

Open Forum Infect Dis. 2025-8-2

[3]
sVEGFR1 up-regulation via EGR1 impairs vascular repair in SFTSV-induced hemorrhage.

EMBO Rep. 2025-8-11

[4]
Long-term clinical sequelae among Sudan ebolavirus disease survivors 2 years post-infection: a matched cohort study.

BMC Med. 2025-7-18

[5]
Nanoscale Mechanical and Morphological Characterization of Ebolavirus-like Particles: Implications for Therapeutic Development.

Int J Mol Sci. 2025-5-28

[6]
Marburg Virus Disease: Pathophysiology, Diagnostic Challenges, and Global Health Preparedness Strategies.

Ann Glob Health. 2025-6-2

[7]
agglutinin enhances entry through interactions at specific -linked glycosylation sites on the virus glycoprotein complex.

J Gen Virol. 2025-6

[8]
Symptoms and determinants of post-traumatic stress disorder and psychological distress among adolescents in Ebola virus disease affected areas: a longitudinal design.

Eur Child Adolesc Psychiatry. 2025-6-5

[9]
Effectiveness of a Teaching Program on Ebola Virus Knowledge Among Nursing Students.

Cureus. 2025-4-23

[10]
Plasmonic Nanoceria: A Plasmon-Enhanced Nanohybrid for Rapid and Sensitive Detection of Ebola Glycoprotein.

ACS Appl Nano Mater. 2025-4-30

本文引用的文献

[1]
Prospects for immunisation against Marburg and Ebola viruses.

Rev Med Virol. 2010-11

[2]
Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study.

Lancet. 2010-5-29

[3]
Preparing a community hospital to manage work-related exposures to infectious agents in BioSafety level 3 and 4 laboratories.

Emerg Infect Dis. 2010-3

[4]
Isolation of genetically diverse Marburg viruses from Egyptian fruit bats.

PLoS Pathog. 2009-7

[5]
Discovery of swine as a host for the Reston ebolavirus.

Science. 2009-7-10

[6]
Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses.

PLoS One. 2009

[7]
Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.

J Virol. 2009-7

[8]
Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule.

Nat Rev Microbiol. 2009-5

[9]
Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007.

Vector Borne Zoonotic Dis. 2009-12

[10]
Experimental vaccine may have saved Hamburg scientist from Ebola fever.

BMJ. 2009-3-23

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索